Results 11 to 20 of about 16,908 (210)
Journal of Family Medicine and Primary Care, 2023 Introduction: Misoprostol is widely used in the medical management of missed abortions. However, pretreatment with Mifepristone has shown to be effective but still not recommended to be used in missed abortions.
Nidhi Gupta +4 more
doaj +2 more sources
Hyperpyrexia After Rectal Misoprostol Administration-A Rare Side Effect of Misoprostol: Case Report
Novelty in Biomedicine, 2022 Background: Misoprostol is a safe drug that is one of the prostaglandins analogs. It has uterotonic solid potential and is good for postpartum hemorrhage (PPH).
Masoumeh Mirzamoradi, Yekta Parsa
doaj +2 more sources
Clinical and Experimental Obstetrics & Gynecology, 2021 Objective: To compare the efficacy and adverse effects of 400 mcg misoprostol for second trimester pregnancy termination via the intravaginal or sublingual route.
Saipin Pongsatha, Theera Tongsong
doaj +2 more sources
Misoprostol versus Letrozol with Misoprostol in Management of First Trimesteric Missed Miscarriage [PDF]
Al-Azhar International Medical Journal, 2021 Background and objective: The objective of this work is to match the security and effectiveness of two treatment modalities (Misoprostol versus Letrozol with Misoprostol) in medical treatment of 1st trimesteric missed miscarriages.
Mofeed Mohammed +2 more
doaj +1 more source
Evaluation of Low-dose and High-dose Intravaginal Misoprostol for Induction of Labour: A Randomised, Double-blinded, Single Centre Study [PDF]
Journal of Clinical and Diagnostic Research, 2022 Introduction: Misoprostol is a synthetic prostaglandin E1 analogue widely used for cervical ripening and labour induction. However, optimal dose of misoprostol required to induce labour is still controversial.
Gowthami Mummalaneni +4 more
doaj +1 more source
Potency and acceptability of oral misoprostol compared with vaginal misoprostol prior to first trimester abortion [PDF]
New Indian Journal of OBGYN, 2020 Objectives: Present study was done to assess the effectiveness and acceptability of oral misoprostol compared with vaginal misoprostol for cervical priming before termination of first trimester pregnancy.
Varsha Kotwal
doaj +1 more source
Majalah Obstetri dan Ginekologi, 2023 HIGHLIGHTS • Oral misoprostol is more effective than vaginal misoprostol in cervical ripening as a part of induction of labor. • Oral misoprostol is as safe as vaginal misoprostol. ABSTRACT Objective: To compare Bishop score changes and labor
Maskasoni Maskasoni +1 more
doaj +1 more source
Comparative Study of Oral and Vaginal Misoprostol for Induction of Labour, Maternal and Foetal Outcome [PDF]
Journal of Clinical and Diagnostic Research, 2013 Background: Misoprostol is a new promising agent for cervical ripening and induction of labour .The ideal dose, route and frequency of administration of misoprostol are still under investigation.
Kambhampati Komala +4 more
doaj +1 more source
Gastric output of pancreatic secretory trypsin inhibitor is increased by misoprostol [PDF]
, 1991 Pancreatic secretory trypsin inhibitor (PSTI) is a potent protease inhibitor that also has growth promoting activity. It has recently been identified in the foveolar cells of the stomach, which secrete mucus.
Batten, J J +14 more
core +1 more source
BMC Women's Health, 2020 Background A wide range of drugs have been studied for first trimester medical abortion. Studies evaluating different regimens, including combination mifepristone and misoprostol and misoprostol alone regimens, show varying results related to safety ...
Ferid A. Abubeker +3 more
doaj +1 more source